{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T12:47:33Z","timestamp":1720010853939},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Special Research Fund of the Ministry of Health for the Non-Profit Sector","award":["201302010"],"award-info":[{"award-number":["201302010"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271833","81471933"],"award-info":[{"award-number":["81271833","81471933"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Major Science and Technology Special Project of China","award":["2012ZX10002007-001-002","2013ZX10002001"],"award-info":[{"award-number":["2012ZX10002007-001-002","2013ZX10002001"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.bcp.2017.10.005","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T20:19:45Z","timestamp":1508012385000},"page":"224-232","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The Ca 2+ \/CaMKK2 axis mediates the telbivudine induced upregulation of creatine kinase: Implications for mechanism of antiviral nucleoside analogs\u2019 side effect"],"prefix":"10.1016","volume":"146","author":[{"given":"Long","family":"Jianfei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma","family":"Chunlai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Bicui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Jiming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Bin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2017.10.005_b0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/AAC.45.1.229-235.2001","article-title":"Antiviral L-nucleosides specific for hepatitis B virus infection","volume":"45","author":"Bryant","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.bcp.2017.10.005_b0010","doi-asserted-by":"crossref","first-page":"E181","DOI":"10.1111\/hepr.12525","article-title":"Efficacy and safety of telbivudine in different trimesters of pregnancy with high viremia for interrupting perinatal transmission of hepatitis B virus","volume":"46","author":"Liu","year":"2015","journal-title":"Hepatol. Res."},{"issue":"1","key":"10.1016\/j.bcp.2017.10.005_b0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.28302","article-title":"Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis","volume":"63","author":"Brown","year":"2016","journal-title":"Hepatology"},{"issue":"25","key":"10.1016\/j.bcp.2017.10.005_b0020","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1056\/NEJMoa066422","article-title":"Telbivudine versus lamivudine in patients with chronic hepatitis B","volume":"357","author":"Lai","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"04","key":"10.1016\/j.bcp.2017.10.005_b0025","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1111\/jvh.12025","article-title":"Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B","volume":"20","author":"Wang","year":"2013","journal-title":"J. Viral Hepat."},{"issue":"01","key":"10.1016\/j.bcp.2017.10.005_b0030","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.gastro.2013.09.031","article-title":"Telbivudine improves renal function in patients with chronic hepatitis B","volume":"146","author":"Gane","year":"2014","journal-title":"Gastroenterology"},{"issue":"03","key":"10.1016\/j.bcp.2017.10.005_b0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2217\/fvl-2015-0015","article-title":"Telbivudine protects against renal impairment in patients with chronic hepatitis B infection","volume":"11","author":"Nan","year":"2016","journal-title":"Future Virol."},{"issue":"4","key":"10.1016\/j.bcp.2017.10.005_b0040","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/hep.26885","article-title":"The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled study","volume":"59","author":"Sun","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bcp.2017.10.005_b0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MAJ.0b013e31821a520e","article-title":"Rhabdomyolysis in a 48-year-old man with hepatitis B-induced cirrhosis","volume":"342","author":"Dang","year":"2011","journal-title":"Am. J. Med. Sci."},{"issue":"02","key":"10.1016\/j.bcp.2017.10.005_b0050","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/j.gastro.2008.10.026","article-title":"2-Year GLOBE trial results: Telbivudine is superior to lamivudine in patients with chronic hepatitis B","volume":"136","author":"Liaw","year":"2009","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bcp.2017.10.005_b0055","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1517\/14740338.2010.507190","article-title":"Safety evaluation of telbivudine","volume":"9","author":"But","year":"2010","journal-title":"Expert Opin. Drug Saf."},{"issue":"33","key":"10.1016\/j.bcp.2017.10.005_b0060","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.3748\/wjg.v19.i33.5575","article-title":"Lactic acidosis during telbivudine treatment for HBV: a case report and literature review","volume":"19","author":"Jin","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bcp.2017.10.005_b0065","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3350\/cmh.2013.19.1.82","article-title":"Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B","volume":"19","author":"Kim","year":"2013","journal-title":"Clin. Mol. Hepatol."},{"issue":"12","key":"10.1016\/j.bcp.2017.10.005_b0070","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1365-2893.2010.01412.x","article-title":"Clinical features and risk factors of creatine kinase elevations and myopathy associated with telbivudine","volume":"18","author":"Zou","year":"2011","journal-title":"J. Viral Hepat."},{"issue":"3","key":"10.1016\/j.bcp.2017.10.005_b0075","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s11096-012-9633-3","article-title":"Telbivudine myopathy in a patient with chronic hepatitis B","volume":"34","author":"Wang","year":"2012","journal-title":"Int. J. Clin. Pharmacy"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2017.10.005_b0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jns.2015.08.1550","article-title":"A novel RRM2B gene variant associated with Telbivudine-induced mitochondrial myopathy","volume":"358","author":"Hern\u00e1ndez-La\u00edn","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2017.10.005_b0085","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1128\/AAC.38.12.2743","article-title":"Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis","volume":"38","author":"Martin","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.bcp.2017.10.005_b0090","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1128\/AAC.03613-14","article-title":"Zidovudine induces downregulation of mitochondrial deoxynucleoside kinases: implications for mitochondrial toxicity of antiviral nucleoside analogs","volume":"58","author":"Sun","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.bcp.2017.10.005_b0095","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jcv.2014.09.016","article-title":"Tenofovir-induced Fanconi syndrome in chronic hepatitis B monoinfected patients that reverted after tenofovir withdrawal","volume":"61","author":"Vigan\u00f2","year":"2014","journal-title":"J. Clin. Virol."},{"issue":"7","key":"10.1016\/j.bcp.2017.10.005_b0100","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1177\/135965350701200704","article-title":"Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors","volume":"12","author":"Venhoff","year":"2007","journal-title":"Antivir. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2017.10.005_b0105","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1128\/AAC.01122-07","article-title":"Entecavir for treatment of hepatitis B virus displays no in vitro mitochondrial toxicity or DNA polymerase gamma inhibition","volume":"52","author":"Mazzucco","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"S5","key":"10.1016\/j.bcp.2017.10.005_b0110","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1002\/hep.22885","article-title":"Side effects of long-term oral antiviral therapy for hepatitis B","volume":"49","author":"Fontana","year":"2009","journal-title":"Hepatology"},{"issue":"14","key":"10.1016\/j.bcp.2017.10.005_b0115","doi-asserted-by":"crossref","first-page":"9556","DOI":"10.1074\/jbc.272.14.9556","article-title":"Stereoisomers of deoxynucleoside 5'-triphosphates as substrates for template-dependent and -independent DNA polymerases","volume":"272","author":"Semizarov","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2017.10.005_b0120","first-page":"119","article-title":"Antiviral beta-L-nucleosides specific for hepatitis B virus infection","volume":"12","author":"Standring","year":"2001","journal-title":"Antivir. Chem. Chemother."},{"issue":"1","key":"10.1016\/j.bcp.2017.10.005_b0125","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.freeradbiomed.2011.10.449","article-title":"Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes","volume":"52","author":"Kwak","year":"2012","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.bcp.2017.10.005_b0130","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s12906-016-1314-7","article-title":"Effects of intermittent pressure imitating rolling manipulation on calcium ion homeostasis in human skeletal muscle cells","author":"Zhang","year":"2016","journal-title":"BMC Complementary Altern. Med."},{"issue":"2","key":"10.1016\/j.bcp.2017.10.005_b0135","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00228-015-1978-9","article-title":"Cumulative incidence and risk factors of creatine kinase elevation associated with telbivudine","volume":"72","author":"Chen","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2017.10.005_b0140","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2217\/fvl-2016-0094","article-title":"Chronic hepatitis B: a critical discussion","volume":"12","author":"Long","year":"2017","journal-title":"Future Virol."},{"key":"10.1016\/j.bcp.2017.10.005_b0145","first-page":"666","article-title":"Comparison of the efficacy of tenofovir disoproxil fumarate and entecavir for initial treatment of patient with chronic hepatitis B in China","author":"Huang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"5\u20136","key":"10.1016\/j.bcp.2017.10.005_b0150","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0891-5849(99)00107-0","article-title":"Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader1","volume":"27","author":"Wang","year":"1999","journal-title":"Free Radical Biol. Med."},{"issue":"8","key":"10.1016\/j.bcp.2017.10.005_b0155","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1093\/nar\/gku152","article-title":"The contribution of mitochondrial thymidylate synthesis in preventing the nuclear genome stress","volume":"42","author":"Lee","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.bcp.2017.10.005_b0160","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/jcb.25149","article-title":"Mitochondrial and oxidative stress response in HepG2 cells following acute and prolonged exposure to antiretroviral drugs","volume":"116","author":"Nagiah","year":"2015","journal-title":"J. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.bcp.2017.10.005_b0165","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/eye.2000.193","article-title":"The role of oxidative stress in diabetic retinopathy","volume":"14","author":"Gurler","year":"2000","journal-title":"Eye"},{"issue":"12","key":"10.1016\/j.bcp.2017.10.005_b0170","doi-asserted-by":"crossref","first-page":"e0144835","DOI":"10.1371\/journal.pone.0144835","article-title":"Cytoprotective role of Nrf2 in electrical pulse stimulated C2C12 myotube","volume":"10","author":"Horie","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.bcp.2017.10.005_b0175","doi-asserted-by":"crossref","first-page":"e0159089","DOI":"10.1371\/journal.pone.0159089","article-title":"Hepatitis B virus middle protein enhances IL-6 production via p38 MAPK\/NF-\u03baB pathways in an ER stress-dependent manner","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"issue":"7453","key":"10.1016\/j.bcp.2017.10.005_b0180","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1038\/nature12189","article-title":"Conserved regulatory elements in AMPK","volume":"498","author":"Chen","year":"2013","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bcp.2017.10.005_b0185","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/emboj\/17.6.1688","article-title":"Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle","volume":"17","author":"Ponticos","year":"1998","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.bcp.2017.10.005_b0190","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nm0595-417","article-title":"Mitochondrial toxicity of antiviral drugs","volume":"1","author":"Lewis","year":"1995","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bcp.2017.10.005_b0195","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1517\/13543784.14.4.511","article-title":"Telbivudine: a new nucleoside analogue for the treatment of chronic hepatitis B","volume":"14","author":"Han","year":"2005","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"1","key":"10.1016\/j.bcp.2017.10.005_b0200","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0092-8674(00)80186-5","article-title":"Altered Ca2+ responses in muscles with combined mitochondrial and cytosolic creatine kinase deficiencies","volume":"89","author":"Steeghs","year":"1997","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bcp.2017.10.005_b0205","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbadis.2005.09.004","article-title":"Mitochondrial creatine kinase in human health and disease","volume":"1762","author":"Schlattner","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.bcp.2017.10.005_b0210","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.tem.2016.06.001","article-title":"The Ca2+\/calmodulin\/CaMKK2 axis: nature\u2019s metabolic CaMshaft","volume":"27","author":"Marcelo","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2017.10.005_b0215","series-title":"Calcium as a Cellular Regulator","author":"Carafoli","year":"1999"},{"issue":"12","key":"10.1016\/j.bcp.2017.10.005_b0220","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.cellsig.2011.07.014","article-title":"Characterization of the CaMKK\u03b2\u2013AMPK signaling complex","volume":"23","author":"Green","year":"2011","journal-title":"Cell. Signal."},{"issue":"5","key":"10.1016\/j.bcp.2017.10.005_b0225","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cmet.2008.02.011","article-title":"Hypothalamic CaMKK2 contributes to the regulation of energy balance","volume":"7","author":"Anderson","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2017.10.005_b0230","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3390\/ijms17101695","article-title":"CaMKK2 suppresses muscle regeneration through the inhibition of myoblast proliferation and differentiation","author":"Ye","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2017.10.005_b0235","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1210\/edrv-14-1-40","article-title":"Regulation of the cell cycle by calcium and calmodulin","volume":"14","author":"Lu","year":"1993","journal-title":"Endocr. Rev."},{"issue":"8","key":"10.1016\/j.bcp.2017.10.005_b0240","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00726-016-2267-3","article-title":"Cellular compartmentation of energy metabolism: creatine kinase microcompartments and recruitment of B-type creatine kinase to specific subcellular sites","volume":"48","author":"Schlattner","year":"2016","journal-title":"Amino Acids"},{"issue":"8","key":"10.1016\/j.bcp.2017.10.005_b0245","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.bbabio.2014.03.020","article-title":"Regulation of brain-type creatine kinase by AMP-activated protein kinase: Interaction, phosphorylation and ER localization","volume":"1837","author":"Ram\u00edrez R\u00edos","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.bcp.2017.10.005_b0250","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s12072-010-9243-x","article-title":"De novo combination of lamivudine and adefovir versus entecavir monotherapy for the treatment of na\u00efve HBeAg-negative chronic hepatitis B patients","volume":"5","author":"Wang","year":"2011","journal-title":"Hep. Intl."},{"issue":"3","key":"10.1016\/j.bcp.2017.10.005_b0255","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/liv.12605","article-title":"Efficacy of telbivudine compared with entecavir in hepatitis B virus-related cirrhosis: 2 year follow-up data","volume":"35","author":"Kim","year":"2015","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.bcp.2017.10.005_b0260","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/jgh.12499","article-title":"Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment","volume":"29","author":"Fung","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.bcp.2017.10.005_b0265","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10096-012-1723-6","article-title":"Lamivudine versus telbivudine in the treatment of chronic hepatitis B: a systematic review and meta-analysis","volume":"32","author":"Jiang","year":"2013","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.bcp.2017.10.005_b0270","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1743-422X-7-211","article-title":"Comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B: a systematic review","author":"Zhao","year":"2010","journal-title":"Virol. J."},{"issue":"8","key":"10.1016\/j.bcp.2017.10.005_b0275","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/jir.2012.0153","article-title":"Peripheral type I interferon receptor correlated with oxidative stress in chronic hepatitis B virus infection","volume":"33","author":"Zhao","year":"2013","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.bcp.2017.10.005_b0280","first-page":"960363","article-title":"Creatine-kinase- and exercise-related muscle damage implications for muscle performance and recovery","author":"Baird","year":"2012","journal-title":"J. Nutr. Metab."},{"issue":"3","key":"10.1016\/j.bcp.2017.10.005_b0285","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/bcp.12360","article-title":"Mechanisms and assessment of statin-related muscular adverse effects","volume":"78","author":"Mo\u00dfhammer","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"20","key":"10.1016\/j.bcp.2017.10.005_b0290","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.jacc.2016.02.071","article-title":"Statin-associated side effects","volume":"67","author":"Thompson","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.bcp.2017.10.005_b0295","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.RES.0000236756.06252.13","article-title":"Ca2+\/calmodulin-dependent protein kinase II phosphorylation of ryanodine receptor does affect calcium sparks in mouse ventricular myocytes","volume":"99","author":"Guo","year":"2006","journal-title":"Circ. Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295217306354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295217306354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T17:04:32Z","timestamp":1659632672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295217306354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":59,"alternative-id":["S0006295217306354"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2017.10.005","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Ca2+\/CaMKK2 axis mediates the telbivudine induced upregulation of creatine kinase: Implications for mechanism of antiviral nucleoside analogs\u2019 side effect","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2017.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}